Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives

GuruFocus.com11-07

Revenue: $9.2 million, up 83% year-over-year. Revenue Units: 161 MyoPro units, up 35% year-over-year. Average Selling Price (ASP): $52,700 per unit. Gross Margin: 75.4% for the third quarter. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481940146?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/e8dxWvc8KB_bt5WvM3oxcw--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/3dbf10c23acf85bc73a6823ace706eb4","is_english":true,"pubTime":"2024-11-07 15:22","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481940146","market":"us","top_or_hot":-1,"title":"Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives","media":"GuruFocus.com","content":"<div>\n<p>Revenue: $9.2 million, up 83% year-over-year.\nRevenue Units: 161 MyoPro units, up 35% year-over-year.\nAverage Selling Price (ASP): $52,700 per unit.\nGross Margin: 75.4% for the third quarter.\n...</p>\n\n<a href=\"https://finance.yahoo.com/news/myomo-inc-myo-q3-2024-072254592.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMyomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-07 15:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/myomo-inc-myo-q3-2024-072254592.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Revenue: $9.2 million, up 83% year-over-year.\nRevenue Units: 161 MyoPro units, up 35% year-over-year.\nAverage Selling Price (ASP): $52,700 per unit.\nGross Margin: 75.4% for the third quarter.\n...</p>\n\n<a href=\"https://finance.yahoo.com/news/myomo-inc-myo-q3-2024-072254592.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MYO","symbol_name":"Myomo Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/myomo-inc-myo-q3-2024-072254592.html","article_id":"2481940146","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/e8dxWvc8KB_bt5WvM3oxcw--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/3dbf10c23acf85bc73a6823ace706eb4"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481940146","pubTimestamp":1730964174,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Revenue Units: 161 MyoPro units, up 35% year-over-year.Operating Loss: $1 million, reduced from $2 million year-over-year.Net Loss: $1 million or $0.03 per share.Cash and Cash Equivalents: $7 million as of September 30, 2024.Backlog: 316 units, representing over $16 million in potential revenue.Fourth Quarter Revenue Guidance: $9.5 million to $10.5 million.Full Year Revenue Guidance: Raised to $30 million to $31 million.GuruFocus has detected 4 Warning Signs with MYO.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Myomo Inc  achieved a record revenue of $9.2 million in Q3 2024, marking an 83% increase over the same period in 2023.Myomo Inc  faces challenges with some Medicare Advantage plans, which are making it difficult for patients and providers to get necessary care, leading to more initial denials and appeals.Q: How quickly can O&P providers start generating revenue, and what are the expectations for this channel in 2025?","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"MYO":"Myomo Inc."},"translate_title":"Myomo Inc(MYO)2024年第三季度收益看涨期权亮点：创纪录的收入和战略增长举措","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MYO":1},"content_text":"Revenue: $9.2 million, up 83% year-over-year.\nRevenue Units: 161 MyoPro units, up 35% year-over-year.\nAverage Selling Price (ASP): $52,700 per unit.\nGross Margin: 75.4% for the third quarter.\nOperating Expenses: $7.9 million, up 43% year-over-year.\nOperating Loss: $1 million, reduced from $2 million year-over-year.\nNet Loss: $1 million or $0.03 per share.\nAdjusted EBITDA: Negative $600,000.\nCash and Cash Equivalents: $7 million as of September 30, 2024.\nBacklog: 316 units, representing over $16 million in potential revenue.\nInternational Revenue: $1.1 million, primarily from Germany.\nFourth Quarter Revenue Guidance: $9.5 million to $10.5 million.\nFull Year Revenue Guidance: Raised to $30 million to $31 million.\n\n\nWarning! GuruFocus has detected 4 Warning Signs with MYO.\n\nRelease Date: November 06, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nMyomo Inc (MYO) achieved a record revenue of $9.2 million in Q3 2024, marking an 83% increase over the same period in 2023.\nThe company successfully added 645 medically qualified candidates to its patient pipeline, a 69% increase from the previous year.\nMyomo Inc (MYO) has entered into its first two contracts with Blue Cross Blue Shield of Massachusetts and Paradigm, representing 3 million covered lives.\nThe company has expanded its manufacturing capacity and plans to move to a larger facility to accommodate expected growth.\nInternational operations, particularly in Germany, continue to perform well with a record $1.1 million in revenue for the quarter.\n\n Negative Points \n\nMyomo Inc (MYO) faces challenges with some Medicare Advantage plans, which are making it difficult for patients and providers to get necessary care, leading to more initial denials and appeals.\nOperating expenses increased by 43% compared to the third quarter of 2023, driven by higher headcount and advertising costs.\nThe company reported a net loss of $1 million for Q3 2024, although this was an improvement from the previous year.\nThere is a potential for gross margin compression as the O&P channel grows, due to lower ASPs in this channel.\nThe process of establishing contracts with payers for in-network status is expected to be a multi-year endeavor, potentially delaying revenue growth from this initiative.\n\n Q & A Highlights \nQ: What percentage of Medicare Part B patients have supplemental insurance, and how does this affect the average selling price (ASP)? A: David Henry, CFO, explained that about 20% to 25% of patients have supplemental insurance, which allows Myomo to recognize additional revenue at delivery. The ASP of $52,700 reflects this, but future ASP growth will depend on the mix of patients with supplemental insurance. The O&P channel might lower ASP as it grows, but this is more of a 2025 issue.\nQ: How quickly can O&P providers start generating revenue, and what are the expectations for this channel in 2025? A: Paul Gudonis, CEO, stated that after initial training, it typically takes 3 to 4 months for O&P providers to start placing orders. The process involves patient evaluation, obtaining medical documentation, and fitting the MyoPro. Initial orders are expected in the first half of 2025, with growth anticipated as more clinics are onboarded.\nQ: What is the current production capacity, and how will the new facility impact this? A: Paul Gudonis mentioned that the current capacity exceeds 80 units per month. The new facility will allow for parallel production, with plans to double capacity over the next six months. The facility offers flexibility for further expansion, potentially adding more workstations or a second shift.\nQ: What is the value of the current backlog, and when will it be recognized? A: David Henry noted that the backlog of 316 units has a net value of over $10 million, considering a 20% dropout rate. Typically, 35% to 40% of the backlog converts to revenue one quarter out, with the remainder realized over the next 3 to 6 months.\nQ: What are Myomo's international expansion plans, particularly in Germany and other markets? A: Paul Gudonis stated that Myomo is focusing on expanding operations in Germany due to successful reimbursement and a strong network of O&P providers. Other markets like France and Italy are being considered, but expansion there is a 2 to 3-year process. The company is also awaiting regulatory approvals in China for future growth.\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.This article first appeared on \nGuruFocus.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481940146"}